NUBEQA 300 mg film-coated tablets, Placebo to BAY1841788 film-coated tablet 300 mg
Phase 3 small_molecule active
Quick answer
NUBEQA 300 mg film-coated tablets, Placebo to BAY1841788 film-coated tablet 300 mg for Localised Very High-Risk Cancer of the Prostate is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Localised Very High-Risk Cancer of the Prostate
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active